Evaluation of moxibustion therapy for urge urinary incontinence after stroke

Evaluation of moxibustion therapy for urge urinary incontinence after stroke: a multicenter, randomized, single-blinded, controlled clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN44706974

Enrollment

120

Registered

2013-12-31

Start date

2013-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urge urinary incontinence after stroke Urological and Genital Diseases Other specified urinary incontinence

Interventions

The 120 participants will be randomly allocated to three different groups: 1. Group A will receive traditional moxibustion therapy and routine care once a day for 4 weeks. Firstly, a certain amount of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male or female, age between 40 and 75 years 2. In-patients with urge urinary incontinence after stroke, according to the diagnosis criteria of the American Stroke Association (ASA) and the International Continence Society (ICS) 3. 4th to 48th week after stroke onset 4. Urge urinary incontinence occurring after stroke onset, or obvious urgent or frequent micturition instead of urinary incontinence 5. Normal consciousness, communication ability and recognition 6. Provided written informed consent

Exclusion criteria

Exclusion criteria: 1. Insufficiency of heart, liver, kidney or other important organs 2. Chronic urinary retention or urinary incontinence before stroke 3. Urge urinary incontinence caused by spinal injury or other diseases 4. Stress urinary incontinence or chronic urinary tract infection 5. Obvious urgent or frequent micturition pre-stroke, due to hyperplasia of prostate gland

Design outcomes

Primary

Measure	Time frame
The mean volume of each micturition will be assessed at the baseline and at the end of the 4th and the 16th week after randomization	—

Secondary

Measure	Time frame
1. The average daily frequency of urination 2. The number of toilet visits at night 3. Quality of life assessment measured by completion of the Incontinence Quality of Life Questionnaire (I-QOL) Chinese version and the Batherl Index (BI) Chinese version The secondary outcome measures above will be assessed at baseline and at the end of the 4th and the 16th week after randomization	—

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026